New bladder cancer cocktail aims to save the bladder
NCT ID NCT05975307
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 2 trial is testing whether a combination of chemotherapy, an immunotherapy drug called toripalimab, and radiation can effectively treat muscle-invasive bladder cancer while allowing patients to keep their bladder. About 71 adults with this type of bladder cancer will receive the drugs first, then those who respond well will get radiation plus more immunotherapy. The main goal is to see if the cancer disappears completely after treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Toripalimab (an immunotherapy drug) combined with chemotherapy (gemcitabine and cisplatin/carboplatin) and radiotherapy
- What this could lead to
- If successful, this could offer a bladder-sparing treatment option for muscle-invasive bladder cancer, avoiding the need for surgical removal of the bladder.
- What could go wrong
- This is a small, early-phase trial with only 71 participants, so results may not apply to everyone. Combining immunotherapy with chemotherapy and radiation can cause significant side effects, and the treatment may not work for all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCLE INVASIVE BLADDER CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cancer Center, Sun Yat-sen University
Guangzhou, Guangdong, 510060, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple supplement soothe Radiation-Damaged rectums?
- Can imaging reveal how radiation shapes marrow recovery?
- Can a targeted drug combo boost chemoradiation in EGFR-Positive lung cancer?
- Can a video call replace a clinic visit for cancer patients on radiotherapy?
- Breast reconstruction after mastectomy: which approach leads to happier patients?
- Two-Drug combo aims to wipe out rectal cancer before surgery